Evidence mapPaperPMID 38529273Full record

ArticleFrontiers in immunology2024

Potential for the development of

Zhen Dong, Zhiqin Liu, Yufeng Xu, Bin Tan, Wenqing Sun, Qin Ai, Zihui Yang, Jianguo Zeng

Open access · goldAbstract readRandomized Controlled Trial, Veterinary
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Mulberry (Animals : an open access journal from MDPI · 2025
    Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Zhen Dong *College of Veterinary Medicine, Hunan Agricultural University, Changsha, China.
Zhiqin LiuCollege of Veterinary Medicine, Hunan Agricultural University, Changsha, China.
Yufeng XuCollege of Veterinary Medicine, Hunan Agricultural University, Changsha, China.
Bin Tan *College of Veterinary Medicine, Hunan Agricultural University, Changsha, China.
Wenqing SunCollege of Veterinary Medicine, Hunan Agricultural University, Changsha, China.
Qin AiDHN Business Division, Wens Foodstuff Group Co., Ltd., Zhaoqing, China.
Zihui YangCollege of Veterinary Medicine, Hunan Agricultural University, Changsha, China.
Jianguo ZengCollege of Veterinary Medicine, Hunan Agricultural University, Changsha, China.
Hunan Agricultural University · CNWen's Food Group (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: A total of 240 one-day-old Arbor Acker broilers were randomly assigned to four groups and fed a basal diet (Con) supplemented with 500, 1000, and 2000 mg/kg TMAE (Low, Medium, and High groups). The growth performance of the broilers was measured on day 21 and day 42. At the end of the trial, the researchers measured slaughter performance and collected serum, liver, spleen, ileum, and intestinal contents to investigate the effects of TMAE on serum biochemistry, antioxidant capacity, immune function, organ coefficient, intestinal morphology, flora composition, and short-chain fatty acids (SCFAs). Results: The results showed that broilers treated with TMAE had a significantly higher average daily gain from 22 to 42 days old compared to the Con group. Various doses of TMAE resulted in different levels of improvement in serum chemistry. High doses increased serum alkaline phosphatase and decreased creatinine. TMAE also increased the antioxidant capacity of serum, liver, and ileum in broilers. Additionally, middle and high doses of TMAE enhanced the innate immune function of the liver (IL-10) and ileum (Occludin) in broilers. Compared to the control group, the TMAE treatment group exhibited an increase in the ratio of villi length to villi crypt in the duodenum. TMAE increased the abundance of beneficial bacteria, such as Conclusion: In conclusion, TMAE is a promising poultry feed additive and 1000 mg/kg is an effective reference dose.

Indexed as

AntioxidantsTaraxacumAnimalsChickensDietary SupplementsFatty Acids, VolatilePoultryAntioxidantsFatty Acids, VolatileAGPs alternativesantioxidantbroilersgrowth performanceimmuneintestinal floraTaraxacum mongolicum

Identifiers

PMID38529273
PMCPMC10961442
OpenAlexW4392652584

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.